<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Causes and contributing risk factors for chronic pancreatitis in children and adolescents
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Causes and contributing risk factors for chronic pancreatitis in children and adolescents
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Causes and contributing risk factors for chronic pancreatitis in children and adolescents
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sarah Jane Schwarzenberg, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Melvin B Heyman, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alison G Hoppin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 10, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The contemporary international definition of chronic pancreatitis is "a pathologic fibroinflammatory syndrome of the pancreas in individuals with genetic, environmental, and/or other risk factors who develop persistent pathologic responses to parenchymal injury or stress." The definition includes a description of the common characteristics of chronic pancreatitis, including structural changes that result in pain syndromes, sometimes progressing to irreversible exocrine, and/or endocrine pancreatic insufficiency [
         <a href="#rid1">
          1-3
         </a>
         ]. The structural changes include diffuse or focal destruction, sclerosis, acinar cell loss, fatty replacement, islet cell loss, inflammatory cell infiltrate, and pancreatic duct abnormalities. Intraductal obstruction may be caused by protein plugs and/or calculi. Extraductal lesions such as trauma, pancreatic or hepatobiliary tumors, or surgical procedures may also lead to chronic inflammatory responses in the pancreas.
        </p>
        <p>
         Chronic pancreatitis represents the end stages of a pathologic process that often includes acute pancreatitis and/or acute recurrent pancreatitis. In most patients, there are multiple factors that together confer susceptibility and drive progressive gland destruction. Finally, the clinical features are variable, such that the rate and extent of fibrosis, calcifications, atrophy, pain, exocrine pancreatic insufficiency, and diabetes mellitus differ markedly among patients.
        </p>
        <p>
         Because the pancreas has a large reserve capacity, symptoms of pancreatic failure do not develop until there is a loss of over 90 percent of pancreatic exocrine function [
         <a href="#rid4">
          4
         </a>
         ]. Most patients with chronic pancreatitis initially experience recurrent abdominal pain, which may progress to persistent pain. Less commonly, patients are asymptomatic or have minimal symptoms until developing signs of advanced disease, such as diabetes mellitus or fat and protein malabsorption. With advances in diagnostic methods, the diagnosis of chronic pancreatitis is becoming more common in children. (See
         <a class="medical medical_review" href="/z/d/html/5896.html" rel="external">
          "Clinical manifestations and diagnosis of chronic and acute recurrent pancreatitis in children"
         </a>
         .)
        </p>
        <p>
         This topic review will outline the risk factors for chronic pancreatitis in children, which become contributing etiologic factors once the disease is established. Related information is available in the following topic reviews:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5896.html" rel="external">
          "Clinical manifestations and diagnosis of chronic and acute recurrent pancreatitis in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5884.html" rel="external">
          "Pancreatitis associated with genetic risk factors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5868.html" rel="external">
          "Endoscopic retrograde cholangiopancreatography (ERCP) for pancreatic disease in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5648.html" rel="external">
          "Overview of the complications of chronic pancreatitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5647.html" rel="external">
          "Chronic pancreatitis: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          OVERVIEW OF RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Contributors to chronic pancreatitis in children are termed "risk factors" rather than "causes" because chronic pancreatitis may be the result of more than one pathophysiologic event. Some risk factors are seen in individuals without pancreatitis, suggesting that, in most cases, a single risk factor is not independently responsible for the pancreatitis or that another risk factor such as a viral infection, gallstone, or trauma may be needed to initiate any inflammatory processes. Once pancreatitis has developed, it is understood that the risk factors likely contribute to the disease progression and that attention should be directed at mitigating or modifying the risk factors if possible. Thus, a careful evaluation of potential risks and etiologies is indicated in children, especially in the earlier stages of disease where appropriate interventions are most likely to be effective.
        </p>
        <p>
         Risk factors for chronic pancreatitis can be grouped according to their pathophysiologic mechanism  (
         <a class="graphic graphic_table graphicRef65173" href="/z/d/graphic/65173.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Genetic
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obstructive
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Toxic/metabolic
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Idiopathic
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Autoimmune
        </p>
        <p>
        </p>
        <p>
         The most common risk factors in children with chronic pancreatitis are genetic variants associated with pancreatitis, followed by anatomic abnormalities of the pancreatic ducts. As in adults, children may have more than one identifiable risk factor (eg, two genetic variants or a genetic variant and an anatomic abnormality). In one registry report, 21 percent of children with chronic pancreatitis had multiple risk factors [
         <a href="#rid5">
          5
         </a>
         ]. Idiopathic chronic pancreatitis, indicating that no risk factors can be identified, is now diagnosed in a small minority of children when a full investigation has been performed [
         <a href="#rid5">
          5
         </a>
         ]. By contrast, in adults, toxic/metabolic causes (particularly alcohol and smoking) predominate in those with etiologies defined [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         In adults, chronic pancreatitis is sometimes categorized by morphology into calcific or noncalcific phenotypes. Calcific pancreatitis is usually associated with alcohol abuse and smoking, although the true etiology is more likely a combination of risk factors [
         <a href="#rid7">
          7
         </a>
         ] (see
         <a class="local">
          'Idiopathic'
         </a>
         below). In children, pancreatic calcifications are less common (12 percent in a multicenter study of 76 children with chronic pancreatitis [
         <a href="#rid5">
          5
         </a>
         ]). It is not common to classify pediatric pancreatitis by morphology.
        </p>
        <p class="headingAnchor" id="H779227259">
         <span class="h1">
          GENETIC
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mutations in genes associated with increased risk of developing chronic pancreatitis are generally grouped into three categories [
         <a href="#rid8">
          8,9
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Variants that increase trypsinogen activation and pancreatic autodigestion
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Variants that increase ductal calcium concentration
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Variants that lead to protein misfolding and acinar cell stress
        </p>
        <p>
        </p>
        <p>
         The degree of risk varies with the mutated genes. Retrospective studies of children with chronic pancreatitis have demonstrated genetic risk factors in 30 to 79 percent of children, depending on the number of genes tested and the ethnicity of the population [
         <a href="#rid5">
          5,10-14
         </a>
         ]. As in adults, children may have more than one genetic risk factor, so testing for a panel of genes is indicated. Chronic pancreatitis has been associated with mutations in each of the following genes:
        </p>
        <p class="headingAnchor" id="H2259249102">
         <span class="h2">
          Increased trypsinogen activation
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           PRSS1
          </em>
         </strong>
         – Mutations in the cationic trypsinogen (serine protease 1) gene, called
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F276000&amp;token=tEpDslnpc0F0kICl%2Fz7sFWdn73fzwsrnK0ZHvwqS9sbNm99hA%2BqoDrgTkFLVgsUz&amp;TOPIC_ID=5895" target="_blank">
          <i>
           PRSS1
          </i>
         </a>
         , are present in up to 80 percent of cases of autosomal dominant hereditary pancreatitis. Prior to the identification of other genetic risk factors for chronic pancreatitis, this was called "hereditary pancreatitis," a term which may now be confusing. Compared with other causes of chronic pancreatitis, patients with this disorder tend to present at a young age. The majority of affected individuals develop symptoms before the age of 20 years, typically at age 10 to 12 years, but often before the age of five [
         <a href="#rid15">
          15
         </a>
         ]. In a study of chronic pancreatitis in children &lt;6 years of age,
         <em>
          PRSS1
         </em>
         and chymotrypsin C (
         <em>
          CTRC
         </em>
         ) mutations were more common than in older children [
         <a href="#rid16">
          16
         </a>
         ]. The most common presentation is severe acute pancreatitis [
         <a href="#rid17">
          17-21
         </a>
         ]. The disorder is associated with an increased risk of pancreatic cancer later in life, although this risk is reduced by lifestyle modifications such as avoidance of smoking [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5884.html" rel="external">
          "Pancreatitis associated with genetic risk factors", section on 'PRSS1 gene'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Mutations in
         <em>
          PRSS1
         </em>
         may also be important in some patients with presumed idiopathic pancreatitis [
         <a href="#rid23">
          23,24
         </a>
         ] and in patients with acute pancreatitis. (See
         <a class="local">
          'Idiopathic'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5641.html" rel="external">
          "Pathogenesis of acute pancreatitis", section on 'Genetic mutations in hereditary pancreatitis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5646.html" rel="external">
          "Etiology and pathogenesis of chronic pancreatitis in adults", section on 'Idiopathic'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           SPINK1
          </em>
         </strong>
         – Mutations in
         <strong>
          s
         </strong>
         erine
         <strong>
          p
         </strong>
         rotease
         <strong>
          in
         </strong>
         hibitor
         <strong>
          K
         </strong>
         azal type
         <strong>
          1
         </strong>
         (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F167790&amp;token=tEpDslnpc0F0kICl%2Fz7sFQZkXc5y3Ni5EtCdXl4313V%2Fl6G7O4vB5JI6glX9WpIQ&amp;TOPIC_ID=5895" target="_blank">
          <i>
           SPINK1
          </i>
         </a>
         , also called pancreatic secretory trypsin inhibitor gene) are associated with chronic pancreatitis. They also occur in the general population (2 percent of healthy individuals carry a "high-risk" mutation) [
         <a href="#rid25">
          25
         </a>
         ], but less than 1 percent of carriers develop pancreatitis [
         <a href="#rid26">
          26
         </a>
         ]. Thus, these mutations probably act as a disease modifier, lowering the threshold for pancreatitis from other genetic, environmental, or anatomic factors (eg, pancreas divisum) [
         <a href="#rid5">
          5,27,28
         </a>
         ] (see
         <a class="local">
          'Congenital anomalies'
         </a>
         below). The majority of patients with
         <em>
          SPINK1
         </em>
         mutations and chronic pancreatitis are heterozygotes and display complex multigenerational inheritance patterns. (See
         <a class="medical medical_review" href="/z/d/html/5884.html" rel="external">
          "Pancreatitis associated with genetic risk factors", section on 'SPINK1 gene'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           CTRC
          </em>
         </strong>
         – Chymotrypsin C (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F601405&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyquPehHn3dMLxG%2BGI8tpLeE&amp;TOPIC_ID=5895" target="_blank">
          CTRC
         </a>
         ) is an enzyme that protects the pancreas by eliminating prematurely activated trypsin. Mutations in the
         <em>
          CTRC
         </em>
         gene and regulatory elements are more common among patients with early-onset chronic pancreatitis (14 percent) compared with the general population (1 percent) [
         <a href="#rid16">
          16,29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2092047000">
         <span class="h2">
          Increased ductal calcium concentration
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           CFTR
          </em>
         </strong>
         – Mutations in the cystic fibrosis transmembrane conductance regulator gene (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F602421&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyqr5%2FL8Flr%2BtdYHuYecJPEB&amp;TOPIC_ID=5895" target="_blank">
          CFTR
         </a>
         ) can increase risk for pancreatitis with or without associated manifestations of cystic fibrosis. As many as 20 to 30 percent of patients with pancreatic
         <strong>
          sufficient
         </strong>
         cystic fibrosis develop chronic pancreatitis [
         <a href="#rid30">
          30
         </a>
         ]. The risk is higher for those with mild compared with severe
         <em>
          CFTR
         </em>
         mutations. Heterozygotes for
         <em>
          CFTR
         </em>
         mutations may also be at risk of chronic pancreatitis. A class of
         <em>
          CFTR
         </em>
         mutations associated with bicarbonate, but not chloride, channel abnormalities have been linked to chronic pancreatitis but not cystic fibrosis [
         <a href="#rid31">
          31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5884.html" rel="external">
          "Pancreatitis associated with genetic risk factors", section on 'CFTR gene'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5858.html" rel="external">
          "Cystic fibrosis: Overview of gastrointestinal disease", section on 'Pancreatitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3194635290">
         <span class="h2">
          Protein misfolding
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           CPA1
          </em>
         </strong>
         – Carboxypeptidase A1 (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F114850&amp;token=tEpDslnpc0F0kICl%2Fz7sFeFrwBDjxb9nersO1%2BvrxP9xIZ4lAajU1t5xkeN9m9RB&amp;TOPIC_ID=5895" target="_blank">
          <i>
           CPA1
          </i>
         </a>
         ), a digestive enzyme, is associated with autosomal dominant hereditary pancreatitis presenting in early childhood [
         <a href="#rid32">
          32,33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           PRSS1
          </em>
         </strong>
         – Protein misfolding is a second potential mechanism of action for this genetic mutation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           CEL-HYB1
          </em>
         </strong>
         – A hybrid allele of the carboxyl-ester lipase gene and its pseudogene. The resultant protein is misfolded, causing toxic stress in the acinar cell [
         <a href="#rid9">
          9,34
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         A diagnosis of celiac disease is associated with a small increased risk for both acute pancreatitis and chronic pancreatitis [
         <a href="#rid35">
          35
         </a>
         ]. Substantial variation in frequency of these gene variants relates to regional origin. Other genetic risk factors are being identified that will soon be available for clinical testing and further inform our understanding of the causes of chronic pancreatitis [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
         Many pancreatitis risk factor genes have been shown to have multiple mutations (for example,
         <em>
          CFTR
         </em>
         has &gt;1000 mutations described), and not all mutations increase pancreatitis risk. A large web-based database can assist the clinician in determining if a reported
         <em>
          CFTR
         </em>
         mutation is important in chronic pancreatitis, available at the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fcftr2.org%2F&amp;token=Zu8VTdNKjwjp6Go6cPhirP8uIWh5pn41S6JpW2ynin4%3D&amp;TOPIC_ID=5895" target="_blank">
          CFTR2 database
         </a>
         , maintained by the Cystic Fibrosis Foundation, Johns Hopkins Medicine, and Sequenom Laboratories [
         <a href="#rid37">
          37
         </a>
         ]. This database is not a substitute for professional genetic counseling.
        </p>
        <p class="headingAnchor" id="H4198943563">
         <span class="h1">
          OBSTRUCTIVE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obstructive (noncalcific) chronic pancreatitis occurs after obstruction of the pancreatic duct by a congenital anomaly, injury, or tumors and other mass lesions. As examples, diseases that affect the proximal intestine, including Crohn disease, celiac disease, or eosinophilic gastroenteropathy, may cause chronic pancreatitis because of inflammation and obstruction of the ampulla. The parenchyma of the pancreas is characterized by diffuse or focal infiltration or replacement by fibrotic tissue, as in chronic fibrosing pancreatitis [
         <a href="#rid38">
          38,39
         </a>
         ]. Obstructive risk factors are found in as many as 33 percent of children with chronic pancreatitis [
         <a href="#rid5">
          5
         </a>
         ]. These problems can be demonstrated with appropriate testing and may be amenable to endoscopic intervention.
        </p>
        <p class="headingAnchor" id="H3539301006">
         <span class="h2">
          Congenital anomalies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pancreas divisum (a condition in which the head and body of the pancreas are separate glands) is the second most common risk factor found in children with chronic pancreatitis, but its role in the pathogenesis of the pancreatitis remains unclear. The anomaly is found in 15 to 45 percent of children with chronic pancreatitis but is also present in approximately 7 percent of healthy children [
         <a href="#rid5">
          5
         </a>
         ]. Of note, approximately one-half of patients with chronic pancreatitis and pancreas divisum also have a genetic polymorphism in
         <em>
          SPINK1
         </em>
         or
         <em>
          CFTR
         </em>
         , as discussed above, suggesting that the genes act as cofactors. Rarely, annular pancreas with pancreaticobiliary malformation may be a cause of pancreatitis [
         <a href="#rid40">
          40
         </a>
         ]. (See
         <a class="local">
          'Genetic'
         </a>
         above.)
        </p>
        <p>
         Chronic pancreatitis has been described in association with biliary cysts (choledochal cysts), polycystic disease (which typically involves the kidney and liver but may affect the pancreas), or duplications of the pancreatic duct, stomach, or duodenum [
         <a href="#rid41">
          41-44
         </a>
         ]. In one series, 16 percent of children with choledochal cyst had pancreatitis at the time of presentation [
         <a href="#rid45">
          45
         </a>
         ]. The patients with pancreatitis were more likely to have choledochal cysts with a long common pancreaticobiliary channel, although a long channel was seen in some children who did not present with pancreatitis. Evaluation of these anomalies using magnetic resonance imaging cholangiopancreatography (MRCP) and treatment with endoscopic retrograde cholangiopancreatography (ERCP) is discussed in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/5868.html" rel="external">
          "Endoscopic retrograde cholangiopancreatography (ERCP) for pancreatic disease in children", section on 'Congenital anomalies'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H397715885">
         <span class="h2">
          Trauma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pancreatic injury from trauma usually is acute and self-limited. However, chronic pancreatitis caused by disruption of the pancreatic ducts has been described, manifested by focal chronic changes and strictures, compression, and obstruction of the pancreatic duct. (See
         <a class="medical medical_review" href="/z/d/html/5868.html" rel="external">
          "Endoscopic retrograde cholangiopancreatography (ERCP) for pancreatic disease in children", section on 'Pancreatic trauma'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1977949101">
         <span class="h2">
          Idiopathic fibrosing pancreatitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Idiopathic fibrosing pancreatitis (IFP) has been described as a rare cause of chronic pancreatitis and obstructive jaundice in children and adolescents [
         <a href="#rid46">
          46-48
         </a>
         ]. Unlike most other forms of chronic pancreatitis in children, fibrosing pancreatitis is characterized by extrinsic compression of the distal common bile duct, with resulting biliary obstruction. Imaging findings often resemble a mass in the pancreatic head [
         <a href="#rid49">
          49
         </a>
         ]. The prominent obstructive features of IFP closely resemble the form of autoimmune pancreatitis that presents with jaundice. One comprehensive literature review, accompanied by a single-center review of historic cases of IFP in children, suggested that IFP has many of the same clinical characteristics as AIP presenting with jaundice and that these may be variants of a single condition [
         <a href="#rid48">
          48
         </a>
         ]. It was noted that 16 percent of children with IFP had associated autoimmune disease (often inflammatory bowel disease) and 35 percent had an immune-mediated disease in a first- or second-degree relative. (See
         <a class="local">
          'Autoimmune'
         </a>
         below.)
        </p>
        <p>
         IFP tends to present with symptoms of jaundice and abdominal pain developing over the course of days or weeks. Many patients eventually develop marked exocrine pancreatic insufficiency, while endocrine insufficiency (diabetes mellitus) is unusual [
         <a href="#rid50">
          50,51
         </a>
         ]. The diagnosis can be established by endoscopic ultrasound or MRCP. The biliary obstruction tends to improve as the pancreas atrophies and has been successfully managed by placement of stents during ERCP [
         <a href="#rid48">
          48-51
         </a>
         ]. However, consultation from a pediatric pancreatotomies' may be useful to guide management of IFP as an autoimmune process.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          TOXIC/METABOLIC
         </span>
         <span class="headingEndMark">
          —
         </span>
         While several toxic/metabolic risk factors contribute to acute pancreatitis in children, their role is less clear for chronic pancreatitis. The following factors have been described in small numbers as contributing to chronic pancreatitis in children [
         <a href="#rid52">
          52
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alcohol and tobacco smoking – These are the most common environmental risk factors for chronic pancreatitis in adults. The possibility of alcohol abuse or smoking also should be considered in adolescents presenting with acute recurrent pancreatitis. Patients with a history of alcohol or tobacco use should be evaluated for other contributing risk factors (genetic, obstructive). It is unknown whether secondhand smoke exposure contributes to the risk for chronic pancreatitis. (See
         <a class="medical medical_review" href="/z/d/html/5646.html" rel="external">
          "Etiology and pathogenesis of chronic pancreatitis in adults", section on 'Smoking'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5646.html" rel="external">
          "Etiology and pathogenesis of chronic pancreatitis in adults", section on 'Alcohol'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Organic acidurias – The branched-chain organic acidurias, including methylmalonic, propionic, and isovaleric aciduria and maple syrup urine disease, are rare causes of chronic pancreatitis but should be considered in children with these disorders [
         <a href="#rid53">
          53
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2927.html" rel="external">
          "Organic acidemias: An overview and specific defects"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Drugs – Medications (including
         <a class="drug drug_pediatric" data-topicid="12606" href="/z/d/drug information/12606.html" rel="external">
          metronidazole
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12582" href="/z/d/drug information/12582.html" rel="external">
          mercaptopurine
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12923" href="/z/d/drug information/12923.html" rel="external">
          azathioprine
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12584" href="/z/d/drug information/12584.html" rel="external">
          mesalamine
         </a>
         , L-asparaginase [
         <a href="#rid54">
          54
         </a>
         ],
         <a class="drug drug_pediatric" data-topicid="12873" href="/z/d/drug information/12873.html" rel="external">
          valproate
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="13393" href="/z/d/drug information/13393.html" rel="external">
          isoniazid
         </a>
         ) are associated with acute pancreatitis more frequently than chronic pancreatitis. If these drugs are the cause of an episode of acute pancreatitis and are not stopped, or if the acute pancreatitis is severe enough, chronic pancreatitis may result. (See
         <a class="medical medical_review" href="/z/d/html/5640.html" rel="external">
          "Etiology of acute pancreatitis", section on 'Medications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic renal failure – Pancreatic disease, including pancreatitis, was found in more than 50 percent of adults with end-stage kidney disease undergoing autopsy [
         <a href="#rid55">
          55,56
         </a>
         ]. Acute, rather than chronic, pancreatitis is more commonly seen and is more common in those on dialysis [
         <a href="#rid52">
          52
         </a>
         ]. Of note, mild or moderate elevations in serum amylase and lipase (eg, one to three times the upper limits of normal) are common in patients with renal failure in the absence of pancreatitis, due to decreased clearance of these enzymes. (See
         <a class="medical medical_review" href="/z/d/html/5643.html" rel="external">
          "Approach to the patient with elevated serum amylase or lipase", section on 'Extrapancreatic disease'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypertriglyceridemia – Hypertriglyceridemia is a relatively rare cause of acute pancreatitis in children. It generally occurs only at very high triglyceride concentrations (eg, &gt;1000 mg/dL), which are typically associated with familial hyper triglyceridemic disorders. Its role in chronic pancreatitis is unclear [
         <a href="#rid52">
          52
         </a>
         ], although it was linked to 13 percent of chronic pancreatitis cases in American adults [
         <a href="#rid57">
          57
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5655.html" rel="external">
          "Hypertriglyceridemia-induced acute pancreatitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypercalcemia – Hypercalcemia (serum calcium &gt;10.7 mg/dL) is an uncommon risk factor for chronic pancreatitis in adults. In most reported cases the hypercalcemia was caused by primary hyperparathyroidism, but other cases were associated with parenteral nutrition or other diseases [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          AUTOIMMUNE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Autoimmune pancreatitis (AIP) is rarely reported in children; a large, international, multicenter cohort of &gt;300 children with chronic pancreatitis found AIP in only 3.9 percent [
         <a href="#rid58">
          58-63
         </a>
         ]. AIP is categorized into two types: type 1, previously lymphoplasmacytic sclerosing pancreatitis, and type 2, or idiopathic duct-centric chronic pancreatitis. Type 1 is more common in adults, and children are more likely to have type 2 AIP. Clinical features of these two forms of AIP overlap [
         <a href="#rid61">
          61,64
         </a>
         ]. Establishing the diagnosis of AIP is important because the disease responds to glucocorticoids or immunomodulatory drugs. (See
         <a class="medical medical_review" href="/z/d/html/5657.html" rel="external">
          "Autoimmune pancreatitis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
         AIP can occur as a primary pancreatic disorder or as part of multiorgan autoimmune disorders (immunoglobulin G4 [IgG4]-related disease). It is usually characterized by relatively mild symptoms, with an enlarged pancreas on abdominal imaging studies, often with obstructive jaundice. Affected children may report abdominal pain, back pain, jaundice, fatigue, and/or weight loss [
         <a href="#rid65">
          65
         </a>
         ]. The pancreatic duct usually is irregularly narrowed, although a variety of morphologies have been described [
         <a href="#rid66">
          66
         </a>
         ]. Adult patients with type 1 AIP often have elevated serum levels of gamma globulin (especially IgG4) [
         <a href="#rid67">
          67
         </a>
         ]. In children, serum IgG4 may not be elevated [
         <a href="#rid68">
          68,69
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5657.html" rel="external">
          "Autoimmune pancreatitis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
         Consensus recommendations for diagnosis of AIP in children have been published [
         <a href="#rid65">
          65
         </a>
         ]. This disorder (often with characteristics of type 2) can be seen in association with other diseases of presumed autoimmune etiology, including sclerosing cholangitis, primary biliary cholangitis, and Sjögren's disease [
         <a href="#rid70">
          70
         </a>
         ]. Acute and chronic pancreatitis have been described in adults and children with inflammatory bowel disease (either Crohn disease or ulcerative colitis) and may precede the diagnosis of the bowel disease [
         <a href="#rid71">
          71,72
         </a>
         ]. A common feature of these reports is the presence of colonic disease. In the setting of these diseases, the pathogenesis of the pancreatitis probably is multifactorial, including side effects of medications, but an autoimmune mechanism is also possible.
        </p>
        <p class="headingAnchor" id="H3734723367">
         <span class="h1">
          IDIOPATHIC
         </span>
         <span class="headingEndMark">
          —
         </span>
         If a thorough evaluation fails to identify risk factors for chronic pancreatitis, the disorder is termed "idiopathic." As genetic testing has become more common, fewer cases of chronic pancreatitis fall into this category. In a large international registry, 11 percent of cases were considered idiopathic but some of these cases did not have genetic testing [
         <a href="#rid5">
          5
         </a>
         ]. Further elucidation of gene mutations associated with chronic pancreatitis may reduce the number of children diagnosed with idiopathic chronic pancreatitis. (See
         <a class="local">
          'Genetic'
         </a>
         above.)
        </p>
        <p>
         Two types of pancreatitis are considered "idiopathic" because their cause is unknown, but they are distinguished by their unique clinical features:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Idiopathic fibrosing pancreatitis (IFP)
         </strong>
         – This type is characterized by fibrotic replacement of the pancreatic tissue, causing biliary obstruction and jaundice. (See
         <a class="local">
          'Idiopathic fibrosing pancreatitis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tropical pancreatitis
         </strong>
         – Tropical pancreatitis (also known as tropical calcific pancreatitis) is a phenotypic description of a form of chronic pancreatitis seen in southern India and other parts of the tropics. Classically, it described chronic pancreatitis with an age of onset most commonly in childhood in which patients typically developed fibrocalculous pancreatic diabetes and malnutrition, often culminating in early death [
         <a href="#rid73">
          73
         </a>
         ]. The histologic changes in the pancreas are similar to those of alcoholic pancreatitis, with fatty infiltration and often calculi [
         <a href="#rid74">
          74
         </a>
         ]. This classical presentation of tropical pancreatitis has become less frequent in the last few decades.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         It was initially thought that tropical pancreatitis was the result of severe malnutrition or cassava (tapioca) ingestion [
         <a href="#rid75">
          75
         </a>
         ]. Mutations in
         <em>
          SPINK1
         </em>
         ,
         <em>
          CFTR
         </em>
         ,
         <em>
          PRSS1
         </em>
         , and
         <em>
          CLDN2
         </em>
         -
         <em>
          MORC4
         </em>
         (claudin 2-MORC family CW-type zinc finger protein 4) variants and other genes associated with chronic pancreatitis in other geographic regions have been identified in some patients with tropical pancreatitis [
         <a href="#rid76">
          76-78
         </a>
         ] (see
         <a class="local">
          'Genetic'
         </a>
         above). Some investigators have suggested that tropical pancreatitis may occur through the same pathways as chronic pancreatitis in other regions or that there may be factors particular to the tropical environment that trigger the disease [
         <a href="#rid79">
          79,80
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          ACUTE RECURRENT PANCREATITIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute recurrent pancreatitis is a phenotypic description rather than a disease classification. It is likely that acute recurrent pancreatitis represents an early step in the progression to chronic pancreatitis. In adults, approximately 70 percent of chronic pancreatitis patients had acute recurrent pancreatitis prior to receiving a diagnosis of chronic pancreatitis [
         <a href="#rid81">
          81
         </a>
         ]. Some patients with severe acute pancreatitis with widespread necrosis are left with scarring and duct destruction that becomes a chronic pancreatitis. (See
         <a class="medical medical_review" href="/z/d/html/5646.html" rel="external">
          "Etiology and pathogenesis of chronic pancreatitis in adults"
         </a>
         .)
        </p>
        <p>
         There is not a clear distinction between diseases that cause recurrent attacks of acute pancreatitis and severe acute pancreatitis and those causing chronic pancreatitis, although the distribution of risk factors is somewhat different. In a multicenter study of 689 children (365 with acute recurrent pancreatitis and 324 with chronic pancreatitis), acute recurrent pancreatitis was more commonly associated with mutations in
         <em>
          CFTR
         </em>
         ; Crohn disease; or risks such as specific medications, toxic-metabolic factors, or hypertriglyceridemia. In contrast, chronic pancreatitis was more commonly associated with female sex, younger age at first acute pancreatitis attack, Asian race, family history of pancreatitis, lower body mass index percentile,
         <em>
          PRSS1
         </em>
         mutations, and pancreas divisum [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1425379820">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112065.html" rel="external">
          "Society guideline links: Chronic pancreatitis and pancreatic exocrine insufficiency"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H21663063">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mechanisms and risk factors
         </strong>
         – Chronic pancreatitis can be associated with a variety of pathophysiologic mechanisms  (
         <a class="graphic graphic_table graphicRef65173" href="/z/d/graphic/65173.html" rel="external">
          table 1
         </a>
         ). In children, genetic and obstructive risk factors predominate. (See
         <a class="local">
          'Overview of risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Genetic
         </strong>
         – The most common genetic risk factors for chronic pancreatitis in children include mutations in the genes encoding cationic trypsinogen (serine protease 1, or
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F276000&amp;token=tEpDslnpc0F0kICl%2Fz7sFWdn73fzwsrnK0ZHvwqS9sbNm99hA%2BqoDrgTkFLVgsUz&amp;TOPIC_ID=5895" target="_blank">
          <i>
           PRSS1
          </i>
         </a>
         ), serine protease inhibitor Kazal type 1 (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F167790&amp;token=tEpDslnpc0F0kICl%2Fz7sFQZkXc5y3Ni5EtCdXl4313V%2Fl6G7O4vB5JI6glX9WpIQ&amp;TOPIC_ID=5895" target="_blank">
          <i>
           SPINK1
          </i>
         </a>
         ), carboxypeptidase A1 (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F114850&amp;token=tEpDslnpc0F0kICl%2Fz7sFeFrwBDjxb9nersO1%2BvrxP9xIZ4lAajU1t5xkeN9m9RB&amp;TOPIC_ID=5895" target="_blank">
          <i>
           CPA1
          </i>
         </a>
         ), and cystic fibrosis transmembrane conductance regulator (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F602421&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyqr5%2FL8Flr%2BtdYHuYecJPEB&amp;TOPIC_ID=5895" target="_blank">
          CFTR
         </a>
         ). (See
         <a class="local">
          'Genetic'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5884.html" rel="external">
          "Pancreatitis associated with genetic risk factors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Obstructive
         </strong>
         – Obstructive chronic pancreatitis occurs after obstruction of the pancreatic duct by a congenital anomaly, traumatic injury, or mass lesions. Magnetic resonance imaging cholangiopancreatography (MRCP) is a valuable tool for diagnosis; endoscopic retrograde cholangiopancreatography (ERCP) may be valuable for treatment. (See
         <a class="local">
          'Obstructive'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5868.html" rel="external">
          "Endoscopic retrograde cholangiopancreatography (ERCP) for pancreatic disease in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Idiopathic fibrosing pancreatitis (IFP) is a rare cause of chronic pancreatitis characterized by extrinsic compression of the distal common bile duct with resulting biliary obstruction, jaundice, and abdominal pain. Imaging findings often resemble a mass in the pancreatic head. The biliary obstruction has been successfully managed by placements of stents during ERCP. (See
         <a class="local">
          'Idiopathic fibrosing pancreatitis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Toxic/metabolic
         </strong>
         – Alcohol and tobacco are the most common risk factors for chronic pancreatitis in adults, and the possibility of alcohol abuse or tobacco use also should be considered in adolescents presenting with recurrent pancreatitis. Other toxic/metabolic causes of chronic pancreatitis include hypercalcemia and hyperlipidemia. (See
         <a class="local">
          'Toxic/metabolic'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Autoimmune
         </strong>
         – Autoimmune pancreatitis (AIP) is more common in adults than children and can be associated with a multiorgan autoimmune disorder. In children, the immunoglobulin G4 (IgG4) elevations typical of AIP may not be present. (See
         <a class="local">
          'Autoimmune'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5657.html" rel="external">
          "Autoimmune pancreatitis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Idiopathic
         </strong>
         – If a thorough evaluation fails to identify risk factors for chronic pancreatitis, the disorder is considered idiopathic. (See
         <a class="local">
          'Idiopathic'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute recurrent pancreatitis
         </strong>
         – There is not a clear distinction between diseases associated with acute recurrent pancreatitis and those associated with chronic pancreatitis. Patients with obstructive and genetic risk factors may have either acute recurrent or chronic pancreatitis. (See
         <a class="local">
          'Acute recurrent pancreatitis'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. Pancreatology 2016; 16:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uc A, Fishman DS. Pancreatic Disorders. Pediatr Clin North Am 2017; 64:685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lew D, Afghani E, Pandol S. Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment. Dig Dis Sci 2017; 62:1702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaskin KJ, Durie PR, Lee L, et al. Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology 1984; 86:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwarzenberg SJ, Bellin M, Husain SZ, et al. Pediatric chronic pancreatitis is associated with genetic risk factors and substantial disease burden. J Pediatr 2015; 166:890.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coté GA, Yadav D, Slivka A, et al. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2011; 9:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whitcomb DC, North American Pancreatitis Study Group. Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers. Clin Transl Gastroenterol 2019; 10:e00027.
          </a>
         </li>
         <li class="breakAll">
          Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, et al. Simpson-Golabi-Behmel Syndrome Type 1. In: GeneReviews, University of Washington, Seattle, 2006.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wertheim-Tysarowska K, Oracz G, Rygiel AM. Genetic Risk Factors in Early-Onset Nonalcoholic Chronic Pancreatitis: An Update. Genes (Basel) 2021; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sultan M, Werlin S, Venkatasubramani N. Genetic prevalence and characteristics in children with recurrent pancreatitis. J Pediatr Gastroenterol Nutr 2012; 54:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee YJ, Kim KM, Choi JH, et al. High incidence of PRSS1 and SPINK1 mutations in Korean children with acute recurrent and chronic pancreatitis. J Pediatr Gastroenterol Nutr 2011; 52:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucidi V, Alghisi F, Dall'Oglio L, et al. The etiology of acute recurrent pancreatitis in children: a challenge for pediatricians. Pancreas 2011; 40:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobczyńska-Tomaszewska A, Bak D, Oralewska B, et al. Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis. J Pediatr Gastroenterol Nutr 2006; 43:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vue PM, McFann K, Narkewicz MR. Genetic Mutations in Pediatric Pancreatitis. Pancreas 2016; 45:992.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keim V, Bauer N, Teich N, et al. Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am J Med 2001; 111:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giefer MJ, Lowe ME, Werlin SL, et al. Early-Onset Acute Recurrent and Chronic Pancreatitis Is Associated with PRSS1 or CTRC Gene Mutations. J Pediatr 2017; 186:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sossenheimer MJ, Aston CE, Preston RA, et al. Clinical characteristics of hereditary pancreatitis in a large family, based on high-risk haplotype. The Midwest Multicenter Pancreatic Study Group (MMPSG). Am J Gastroenterol 1997; 92:1113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whitcomb DC. Genetic predispositions to acute and chronic pancreatitis. Med Clin North Am 2000; 84:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sibert JR. Hereditary pancreatitis in England and Wales. J Med Genet 1978; 15:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004; 2:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rebours V, Boutron-Ruault MC, Schnee M, et al. The natural history of hereditary pancreatitis: a national series. Gut 2009; 58:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhan W, Shelton CA, Greer PJ, et al. Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts. Pancreas 2018; 47:924.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Creighton J, Lyall R, Wilson DI, et al. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet 1999; 354:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 1999; 117:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fink EN, Kant JA, Whitcomb DC. Genetic counseling for nonsyndromic pancreatitis. Gastroenterol Clin North Am 2007; 36:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pfützer RH, Barmada MM, Brunskill AP, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000; 119:615.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garg PK, Khajuria R, Kabra M, Shastri SS. Association of SPINK1 gene mutation and CFTR gene polymorphisms in patients with pancreas divisum presenting with idiopathic pancreatitis. J Clin Gastroenterol 2009; 43:848.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bertin C, Pelletier AL, Vullierme MP, et al. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Am J Gastroenterol 2012; 107:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grabarczyk AM, Oracz G, Wertheim-Tysarowska K, et al. Chymotrypsinogen C Genetic Variants, Including c.180TT, Are Strongly Associated With Chronic Pancreatitis in Pediatric Patients. J Pediatr Gastroenterol Nutr 2017; 65:652.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ooi CY, Dorfman R, Cipolli M, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology 2011; 140:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LaRusch J, Jung J, General IJ, et al. Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis. PLoS Genet 2014; 10:e1004376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sahin-Tóth M. Genetic risk in chronic pancreatitis: the misfolding-dependent pathway. Curr Opin Gastroenterol 2017; 33:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Witt H, Beer S, Rosendahl J, et al. Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet 2013; 45:1216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hegyi E. Carboxyl ester lipase (CEL) hybrid genes and chronic pancreatitis. The saga continues. Pancreatology 2019; 19:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alkhayyat M, Saleh MA, Abureesh M, et al. The Risk of Acute and Chronic Pancreatitis in Celiac Disease. Dig Dis Sci 2021; 66:2691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shelton CA, Whitcomb DC. Genetics and treatment options for recurrent acute and chronic pancreatitis. Curr Treat Options Gastroenterol 2014; 12:359.
          </a>
         </li>
         <li class="breakAll">
          Clinical and Functional Translation of CFTR database (CFTR2). Available at: https://www.cftr2.org/ (Accessed on December 12, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewin-Smith MR, Dipalma JS, Hoy GR, et al. Chronic fibrosing pancreatitis in childhood: report of a case and literature review. Pediatr Pathol Lab Med 1996; 16:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elitsur Y, Siddiqui SY, Sloven D, et al. Chronic pancreatitis with diffuse fibrosis in early childhood. Pancreas 1989; 4:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Komuro H, Gotoh C, Urita Y, et al. A pediatric case of an unusual type of annular pancreas presenting with duodenopancreatic reflux. Pediatr Surg Int 2012; 28:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kamelmaz I, Elitsur Y. Pancreas divisum--the role of ERCP in children. W V Med J 1999; 95:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guelrud M, Morera C, Rodriguez M, et al. Normal and anomalous pancreaticobiliary union in children and adolescents. Gastrointest Endosc 1999; 50:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koc-Kuś J. [Contemporary opinions on the etiology of chronic pancreatitis]. Wiad Lek 1999; 52:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kamisawa T, Egawa N, Tsuruta K, et al. Pancreatitis associated with congenital abnormalities of the pancreaticobiliary system. Hepatogastroenterology 2005; 52:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hukkinen M, Koivusalo A, Lindahl H, et al. Increasing occurrence of choledochal malformations in children: a single-center 37-year experience from Finland. Scand J Gastroenterol 2014; 49:1255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amerson JL, Ricketts RR. Idiopathic fibrosing pancreatitis: a rare cause of obstructive jaundice in children. Am Surg 1996; 62:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harb R, Naon H. Idiopathic fibrosing pancreatitis in a 3-year-old girl: a case report and review of the literature. J Pediatr Surg 2005; 40:1335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scheers I, Chavhan GB, Chami R, et al. Clinical Characteristics and Long-term Outcomes of Children With Fibrosing Pancreatitis. J Pediatr Gastroenterol Nutr 2020; 70:801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buxbaum JL, Eloubeidi MA, Varadarajulu S. Utility of EUS-guided FNA in the management of children with idiopathic fibrosing pancreatitis. J Pediatr Gastroenterol Nutr 2011; 52:482.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sylvester FA, Shuckett B, Cutz E, et al. Management of fibrosing pancreatitis in children presenting with obstructive jaundice. Gut 1998; 43:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Matary W, Casson D, Hodges S, et al. Successful conservative management of idiopathic fibrosing pancreatitis in children. Eur J Pediatr 2006; 165:560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Husain SZ, Morinville V, Pohl J, et al. Toxic-metabolic Risk Factors in Pediatric Pancreatitis: Recommendations for Diagnosis, Management, and Future Research. J Pediatr Gastroenterol Nutr 2016; 62:609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahler SG, Sherwood WG, Woolf D, et al. Pancreatitis in patients with organic acidemias. J Pediatr 1994; 124:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oparaji JA, Rose F, Okafor D, et al. Risk Factors for Asparaginase-associated Pancreatitis: A Systematic Review. J Clin Gastroenterol 2017; 51:907.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Avram MM. High prevalence of pancreatic disease in chronic renal failure. Nephron 1977; 18:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaziri ND, Dure-Smith B, Miller R, Mirahmadi M. Pancreatic pathology in chronic dialysis patients--an autopsy study of 78 cases. Nephron 1987; 46:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conwell DL, Banks PA, Sandhu BS, et al. Validation of Demographics, Etiology, and Risk Factors for Chronic Pancreatitis in the USA: A Report of the North American Pancreas Study (NAPS) Group. Dig Dis Sci 2017; 62:2133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gargouri L, Ponsot P, Viala J, et al. Recurrent autoimmune pancreatitis in a 10-year-old boy. J Pediatr Gastroenterol Nutr 2009; 48:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fukumori K, Shakado S, Miyahara T, et al. Atypical manifestations of pancreatitis with autoimmune phenomenon in an adolescent female. Intern Med 2005; 44:886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997; 41:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujii LL, Chari ST, El-Youssef M, et al. Pediatric pancreatic EUS-guided trucut biopsy for evaluation of autoimmune pancreatitis. Gastrointest Endosc 2013; 77:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004; 99:1605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scheers I, Palermo JJ, Freedman S, et al. Autoimmune Pancreatitis in Children: Characteristic Features, Diagnosis, and Management. Am J Gastroenterol 2017; 112:1604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hart PA, Krishna SG, Okazaki K. Diagnosis and Management of Autoimmune Pancreatitis. Curr Treat Options Gastroenterol 2017; 15:538.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scheers I, Palermo JJ, Freedman S, et al. Recommendations for Diagnosis and Management of Autoimmune Pancreatitis in Childhood: Consensus From INSPPIRE. J Pediatr Gastroenterol Nutr 2018; 67:232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okazaki K, Uchida K, Matsushita M, Takaoka M. Autoimmune pancreatitis. Intern Med 2005; 44:1215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344:732.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friedlander J, Quiros JA, Morgan T, et al. Diagnosis of autoimmune pancreatitis vs neoplasms in children with pancreatic mass and biliary obstruction. Clin Gastroenterol Hepatol 2012; 10:1051.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Srinath AI, Lowe ME. Pediatric pancreatitis. Pediatr Rev 2013; 34:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002; 51:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Broide E, Dotan I, Weiss B, et al. Idiopathic pancreatitis preceding the diagnosis of inflammatory bowel disease is more frequent in pediatric patients. J Pediatr Gastroenterol Nutr 2011; 52:714.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lorenzo D, Maire F, Stefanescu C, et al. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2018; 16:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balakrishnan V, Sauniere JF, Hariharan M, Sarles H. Diet, pancreatic function, and chronic pancreatitis in south India and France. Pancreas 1988; 3:30.
          </a>
         </li>
         <li class="breakAll">
          Pitchumoni CS, Mohan V. Juvenile tropical pancreatitis. In: Pediatric Gastrointestinal Disease, 4th ed, Walker WA, Goulet O, Kleinman RE, et al (Eds), BC Decker, 2004. Vol 2, p.1598.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarles H, Augustine P, Laugier R, et al. Pancreatic lesions and modifications of pancreatic juice in tropical chronic pancreatitis (tropical calcific diabetes). Dig Dis Sci 1994; 39:1337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatia E, Choudhuri G, Sikora SS, et al. Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology 2002; 123:1020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider A, Suman A, Rossi L, et al. SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 2002; 123:1026.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paliwal S, Bhaskar S, Nageshwar Reddy D, et al. Association Analysis of PRSS1-PRSS2 and CLDN2-MORC4 Variants in Nonalcoholic Chronic Pancreatitis Using Tropical Calcific Pancreatitis as Model. Pancreas 2016; 45:1153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paliwal S, Bhaskar S, Chandak GR. Genetic and phenotypic heterogeneity in tropical calcific pancreatitis. World J Gastroenterol 2014; 20:17314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Subhash R, Iyoob VA, Natesh B. Tropical calcific pancreatitis. Clin Gastroenterol Hepatol 2012; 10:A30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yadav D, O'Connell M, Papachristou GI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol 2012; 107:1096.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uc A, Cress GA, Wang F, et al. Analysis of INSPPIRE-2 Cohort: Risk Factors and Disease Burden in Children With Acute Recurrent or Chronic Pancreatitis. J Pediatr Gastroenterol Nutr 2022; 75:643.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5895 Version 31.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26924663" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28502446" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Pancreatic Disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28501969" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6689652" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25556020" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Pediatric chronic pancreatitis is associated with genetic risk factors and substantial disease burden.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21029787" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31166201" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31166201" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34065437" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Genetic Risk Factors in Early-Onset Nonalcoholic Chronic Pancreatitis: An Update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22094894" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Genetic prevalence and characteristics in children with recurrent pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21415673" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : High incidence of PRSS1 and SPINK1 mutations in Korean children with acute recurrent and chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21499205" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The etiology of acute recurrent pancreatitis in children: a challenge for pediatricians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16954950" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26692446" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Genetic Mutations in Pediatric Pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11755505" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28502372" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Early-Onset Acute Recurrent and Chronic Pancreatitis Is Associated with PRSS1 or CTRC Gene Mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9219780" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Clinical characteristics of hereditary pancreatitis in a large family, based on high-risk haplotype. The Midwest Multicenter Pancreatic Study Group (MMPSG)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10872412" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Genetic predispositions to acute and chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/671483" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Hereditary pancreatitis in England and Wales.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15017610" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Clinical and genetic characteristics of hereditary pancreatitis in Europe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18755888" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The natural history of hereditary pancreatitis: a national series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30113427" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10406366" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10381903" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17533082" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Genetic counseling for nonsyndromic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10982753" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19593166" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Association of SPINK1 gene mutation and CFTR gene polymorphisms in patients with pancreas divisum presenting with idiopathic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22158025" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28968289" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Chymotrypsinogen C Genetic Variants, Including c.180TT, Are Strongly Associated With Chronic Pancreatitis in Pediatric Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20923678" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25033378" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28650851" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Genetic risk in chronic pancreatitis: the misfolding-dependent pathway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23955596" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Variants in CPA1 are strongly associated with early onset chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31164321" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Carboxyl ester lipase (CEL) hybrid genes and chronic pancreatitis. The saga continues.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32809104" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The Risk of Acute and Chronic Pancreatitis in Celiac Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24954874" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Genetics and treatment options for recurrent acute and chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24954874" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Genetics and treatment options for recurrent acute and chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9025865" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Chronic fibrosing pancreatitis in childhood: report of a case and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2668934" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Chronic pancreatitis with diffuse fibrosis in early childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22358254" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : A pediatric case of an unusual type of annular pancreas presenting with duodenopancreatic reflux.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9949690" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Pancreas divisum--the role of ERCP in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10425411" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Normal and anomalous pancreaticobiliary union in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10503045" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : [Contemporary opinions on the etiology of chronic pancreatitis].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15783036" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Pancreatitis associated with congenital abnormalities of the pancreaticobiliary system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25123318" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Increasing occurrence of choledochal malformations in children: a single-center 37-year experience from Finland.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8600851" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Idiopathic fibrosing pancreatitis: a rare cause of obstructive jaundice in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16080944" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Idiopathic fibrosing pancreatitis in a 3-year-old girl: a case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32443035" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Clinical Characteristics and Long-term Outcomes of Children With Fibrosing Pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21407109" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Utility of EUS-guided FNA in the management of children with idiopathic fibrosing pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9824357" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Management of fibrosing pancreatitis in children presenting with obstructive jaundice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16552545" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Successful conservative management of idiopathic fibrosing pancreatitis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26594832" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Toxic-metabolic Risk Factors in Pediatric Pancreatitis: Recommendations for Diagnosis, Management, and Future Research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8301430" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Pancreatitis in patients with organic acidemias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28375864" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Risk Factors for Asparaginase-associated Pancreatitis: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/846627" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : High prevalence of pancreatic disease in chronic renal failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3658062" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pancreatic pathology in chronic dialysis patients--an autopsy study of 78 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28600657" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Validation of Demographics, Etiology, and Risk Factors for Chronic Pancreatitis in the USA: A Report of the North American Pancreas Study (NAPS) Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19274796" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Recurrent autoimmune pancreatitis in a 10-year-old boy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16157994" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Atypical manifestations of pancreatitis with autoimmune phenomenon in an adolescent female.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9301509" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Non-alcoholic duct destructive chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23433594" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Pediatric pancreatic EUS-guided trucut biopsy for evaluation of autoimmune pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15307882" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Autoimmune chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28374818" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Autoimmune Pancreatitis in Children: Characteristic Features, Diagnosis, and Management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28842855" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Diagnosis and Management of Autoimmune Pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29746340" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Recommendations for Diagnosis and Management of Autoimmune Pancreatitis in Childhood: Consensus From INSPPIRE.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16415540" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Autoimmune pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11236777" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : High serum IgG4 concentrations in patients with sclerosing pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22732272" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Diagnosis of autoimmune pancreatitis vs neoplasms in children with pancreatic mass and biliary obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23378615" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Pediatric pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12077078" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Autoimmune related pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21478760" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Idiopathic pancreatitis preceding the diagnosis of inflammatory bowel disease is more frequent in pediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28782667" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3362842" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Diet, pancreatic function, and chronic pancreatitis in south India and France.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3362842" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Diet, pancreatic function, and chronic pancreatitis in south India and France.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8200268" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Pancreatic lesions and modifications of pancreatic juice in tropical chronic pancreatitis (tropical calcific diabetes).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12360463" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12360464" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26784911" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Association Analysis of PRSS1-PRSS2 and CLDN2-MORC4 Variants in Nonalcoholic Chronic Pancreatitis Using Tropical Calcific Pancreatitis as Model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25516642" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Genetic and phenotypic heterogeneity in tropical calcific pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22446928" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Tropical calcific pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22613906" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Natural history following the first attack of acute pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35976273" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Analysis of INSPPIRE-2 Cohort: Risk Factors and Disease Burden in Children With Acute Recurrent or Chronic Pancreatitis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
